These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1571932)

  • 1. Effect of WEB 2086 on myocardial infarct size and regional blood flow in the dog.
    Leong LL; Stephens CJ; Sturm MJ; Taylor RR
    Cardiovasc Res; 1992 Feb; 26(2):126-32. PubMed ID: 1571932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage.
    Black SC; Driscoll EM; Lucchesi BR
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):997-1005. PubMed ID: 1282605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
    Auchampach JA; Pieper GM; Cavero I; Gross GJ
    Basic Res Cardiol; 1998 Oct; 93(5):361-71. PubMed ID: 9833148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts.
    Koltai M; Tosaki A; Hosford D; Esanu A; Braquet P
    Cardiovasc Res; 1991 May; 25(5):391-7. PubMed ID: 1855244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a PAF antagonist on ischemic myocardial damage and arrhythmia in the dog.
    Leong LL; Sturm MJ; Papadimitriou JM; Stephens CJ; Taylor RR
    J Mol Cell Cardiol; 1992 Jun; 24(6):641-9. PubMed ID: 1518080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs.
    Maruyama M; Farber NE; Vercellotti GM; Jacob HS; Gross GJ
    Am Heart J; 1990 Sep; 120(3):510-20. PubMed ID: 2389687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning with supply-demand imbalance limits infarct size in dog heart.
    Iwamoto T; Bai XJ; Downey HF
    Cardiovasc Res; 1993 Nov; 27(11):2071-6. PubMed ID: 8287420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
    Vander Heide RS; Schwartz LM; Reimer KA
    Cardiovasc Res; 1994 Oct; 28(10):1526-32. PubMed ID: 8001041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor and WEB-2086 directly modulate rat cardiomyocyte contractility.
    Delbridge LM; Stewart AG; Goulter CM; Morgan TO; Harris PJ
    J Mol Cell Cardiol; 1994 Feb; 26(2):185-93. PubMed ID: 8006979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion.
    Grover GJ; Dzwonczyk S; Parham CS
    Cardiovasc Res; 1993 Sep; 27(9):1613-8. PubMed ID: 8287438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of factors influencing myocardial infarct size in unconscious dogs.
    Vandeplassche G; Hermans C; Van Haecke J; Wouters L; Borgers M; Flameng W
    Cardiovasc Res; 1991 Oct; 25(10):844-54. PubMed ID: 1747878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic reperfusion to remove ischaemic catabolites prior to arterial reperfusion does not limit the size of myocardial infarcts in dogs.
    Tanaka M; Earnhardt RC; Murry CE; Richard VJ; Jennings RB; Reimer KA
    Cardiovasc Res; 1991 Jan; 25(1):7-16. PubMed ID: 2054833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs.
    Endo T; Nejima J; Fujita S; Kiuchi K; Iida N; Kikuchi K; Hayakawa H; Okumura H
    Circulation; 1986 Aug; 74(2):420-30. PubMed ID: 3731430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of chronic hypoxemia on regional myocardial blood flow in the conscious dog after acute coronary artery occlusion.
    Bishop SP; White FC; Bloor CM
    Am J Pathol; 1977 Dec; 89(3):541-53. PubMed ID: 596417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous metoprolol preceding thrombolysis in acute thrombotic myocardial infarction in the dog; effects on infarct size, myocardial blood flow, and left ventricular function.
    Zmudka K; Dubiel J; Vanhaecke J; Flameng W; De Geest H
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):78-86. PubMed ID: 7521494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of immature recruitable collaterals on myocardial blood flow and infarct size after acute coronary occlusion.
    Ramanathan KB; Wilson JL; Ingram LA; Mirvis DM
    J Lab Clin Med; 1995 Jan; 125(1):66-71. PubMed ID: 7822947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
    Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of WEB 2086 on the protective role of preconditioning against arrhythmias in rats.
    Sariahmetoğlu M; Cakici I; Kanzik I
    Pharmacol Res; 1998 Sep; 38(3):173-8. PubMed ID: 9782066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.